AU6937700A - Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition - Google Patents

Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition

Info

Publication number
AU6937700A
AU6937700A AU69377/00A AU6937700A AU6937700A AU 6937700 A AU6937700 A AU 6937700A AU 69377/00 A AU69377/00 A AU 69377/00A AU 6937700 A AU6937700 A AU 6937700A AU 6937700 A AU6937700 A AU 6937700A
Authority
AU
Australia
Prior art keywords
omeprazole
composition
spectroscopic measurement
isomer ratio
raman spectroscopic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69377/00A
Other languages
English (en)
Inventor
Frederick D Sancilio
Grayson Walker Stowell
Robert R. Whittle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AAIPharma Inc
Original Assignee
Applied Analytical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Analytical Industries Inc filed Critical Applied Analytical Industries Inc
Publication of AU6937700A publication Critical patent/AU6937700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AU69377/00A 1999-08-26 2000-08-23 Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition Abandoned AU6937700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15087899P 1999-08-26 1999-08-26
US60150878 1999-08-26
PCT/US2000/023368 WO2001013919A1 (en) 1999-08-26 2000-08-23 Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition

Publications (1)

Publication Number Publication Date
AU6937700A true AU6937700A (en) 2001-03-19

Family

ID=22536394

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69377/00A Abandoned AU6937700A (en) 1999-08-26 2000-08-23 Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition

Country Status (10)

Country Link
US (1) US20060014799A1 (https=)
EP (1) EP1206263A1 (https=)
JP (1) JP2003507721A (https=)
KR (1) KR20020043565A (https=)
CN (2) CN1379670A (https=)
AU (1) AU6937700A (https=)
CA (1) CA2382838A1 (https=)
MX (1) MXPA02002068A (https=)
WO (1) WO2001013919A1 (https=)
ZA (2) ZA200201519B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
CA2443605A1 (en) * 2001-04-20 2002-10-31 Linda Whittall Process for purifying 6-methoxy omeprazole
US7855082B1 (en) 2001-10-31 2010-12-21 Astrazeneca Ab Raman spectroscopic method for determining the ratio of 5-methoxy and 6-methoxy isomers of omeprazole
DE10322439A1 (de) * 2003-05-19 2004-12-09 Bayer Ag Verfahren und Vorrichtung zur Bestimmung der Isomerenzusammensetzung bei Isocyanat-Herstellprozessen
FR2937418B1 (fr) * 2008-10-17 2010-12-31 France Etat Ponts Chaussees Procede de determination de la phase solide/liquide.
MX2013003038A (es) * 2010-09-17 2013-05-01 Abbvie Inc Espectroscopia raman para operaciones de bioprocesos.
CN103833731B (zh) * 2011-12-01 2016-03-23 四川大学 手性亚砜类化合物及其盐的制备新方法和晶型
CN103006610B (zh) * 2013-01-04 2014-10-22 青岛大学 一种埃索美拉唑钠肠溶片剂及其制备方法
CN103408532A (zh) * 2013-08-02 2013-11-27 常州大学 一种质子泵抑制剂的制备方法
US9599565B1 (en) * 2013-10-02 2017-03-21 Ondax, Inc. Identification and analysis of materials and molecular structures
US9587983B1 (en) 2015-09-21 2017-03-07 Ondax, Inc. Thermally compensated optical probe
EP3472582A4 (en) * 2016-06-16 2020-03-18 Valisure LLC SPECTROSCOPIC ANALYSIS METHODS AND SYSTEMS
CN113092445A (zh) * 2021-04-14 2021-07-09 中朗正健(苏州)生物技术有限公司 一种对减肥类保健食品中违法添加奥美拉唑的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US5638172A (en) * 1994-05-27 1997-06-10 Eastman Chemical Company On-line quantitative analysis of chemical compositions by raman spectrometry
US6040906A (en) * 1996-07-11 2000-03-21 Harhay; Gregory P. Resonance raman spectroscopy for identifying and quantitating biomatter, organic, and inorganic analytes
US5850623A (en) * 1997-03-14 1998-12-15 Eastman Chemical Company Method for standardizing raman spectrometers to obtain stable and transferable calibrations

Also Published As

Publication number Publication date
ZA200201521B (en) 2003-05-22
JP2003507721A (ja) 2003-02-25
CN1379670A (zh) 2002-11-13
EP1206263A1 (en) 2002-05-22
US20060014799A1 (en) 2006-01-19
WO2001013919A1 (en) 2001-03-01
MXPA02002068A (es) 2003-08-20
CA2382838A1 (en) 2001-03-01
KR20020043565A (ko) 2002-06-10
CN1880312A (zh) 2006-12-20
ZA200201519B (en) 2003-05-22

Similar Documents

Publication Publication Date Title
AU2001276456A1 (en) Compact spectroscopic ellipsometer
AU2884401A (en) Photothermic transducing spectroscopic analyzer
AU2001285998A1 (en) Device for supporting chromophoric elements
AU2002229065A1 (en) Compositions containing inclusion complexes
AU2882801A (en) Azepine derivatives
AU2270101A (en) Pharmaceutical kit
AU2001295657A1 (en) Formulation containing wax-esters
AU6937700A (en) Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition
AU2001218494A1 (en) Resolution of the enantiomers of amlodipine
AU2002216059A1 (en) Oral bleaching composition
AU2001269959A1 (en) Top loading customer bridge
AU2001290075A1 (en) Novel alkanoic acid derivatives
AU2001239765A1 (en) Novel compounds
AU5841600A (en) Jewelry piece set
AU2001225164A1 (en) Compositions with enhanced oral bioavailability
AU5086899A (en) Tape measure
AU3887200A (en) Improved tape measure
AU3812900A (en) Sample dispenser
AU2001286191A1 (en) Quinolizine derivatives
AU5568300A (en) Novel dihydropyridine derivative
AU2001252575A1 (en) Novel tricyclic compounds
AU7879600A (en) Interferometric residual-stress analysis
AU2002213362A1 (en) Novel substituted-polyaryl chromophoric compounds
AU2002349689A1 (en) Spectroscope
AU9517501A (en) Composition containing leishmania LIP2A

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase